Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
WuXi AppTec SHSE:603259 |
320,73 B | 29,04% | 6/6 | 16,77% | 39,55% | 26,96% | UP |
|
Pharmaron Beijing SZSE:300759 |
52,44 B | 20,79% | 5/6 | 31,44% | 69,85% | 26,33% | UP |
|
Hangzhou Tigermed Consulting SZSE:300347 |
46,99 B | 10,66% | 4/6 | 21,16% | 53,92% | 16,49% | UP |
|
XtalPi Holdings SEHK:2228 |
42,17 B | 465,97% | 1/2 | -31,66% | -41,89% | 10,20% | UP |
|
Joinn Laboratories(China)Co.,Ltd. SHSE:603127 |
26,09 B | 5,25% | 3/5 | 145,04% | -67,71% | -4,39% | UP |
|
Genscript Biotech SEHK:1548 |
28,03 B | 13,53% | 3/6 | 58,57% | 20,45% | 36,77% | DOWN |
|
Beijing Hotgen Biotech SHSE:688068 |
10,90 B | 0,00% | 4/5 | 0,00% | 0,00% | -100,00% | DOWN |
|
HitGen SHSE:688222 |
10,67 B | 27,40% | 6/6 | 44,14% | 56,98% | 1,87% | UP |
|
Shanghai Medicilon SHSE:688202 |
8,86 B | 0,00% | 1/5 | 0,00% | 15,29% | -100,00% | UP |
|
PharmaBlock Sciences (Nanjing) SZSE:300725 |
8,85 B | 13,56% | 3/5 | 267,34% | 16,56% | -100,00% | DOWN |
|
Shanghai Runda Medical Technology SHSE:603108 |
7,71 B | -14,23% | 2/5 | 20,49% | -15,44% | -100,00% | DOWN |
|
Beijing Sun-Novo Pharmaceutical Research SHSE:688621 |
7,27 B | 0,00% | 0/0 | 240,75% | -12,06% | -100,00% | UP |
|
Novogene SHSE:688315 |
5,87 B | -1,36% | 4/6 | 127,16% | 20,17% | 9,86% | DOWN |
|
R&G PharmaStudies SZSE:301333 |
6,45 B | 0,34% | 0/0 | 9,78% | -18,07% | 25,08% | UP |
|
Hangzhou Bio-Sincerity Pharma-Tech SZSE:301096 |
5,95 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
|
PharmaResources (Shanghai) SZSE:301230 |
5,48 B | 0,00% | 0/0 | 194,48% | -51,78% | -100,00% | UP |
|
SMO ClinPlus CO.,LTD. SZSE:301257 |
4,73 B | 0,00% | 0/0 | 0,00% | 0,00% | -47,36% | UP |
|
Shanghai Obio Technology (Group) Corp. SHSE:688238 |
4,50 B | 0,00% | 0/0 | 35,30% | 0,00% | 63,73% | UP |
|
Boji Medical Technology SZSE:300404 |
3,92 B | 0,00% | 0/0 | 102,31% | 17,31% | -100,00% | UP |
|
Viva Biotech Holdings SEHK:1873 |
4,12 B | -13,50% | 2/4 | 0,00% | -543,32% | 44,62% | UP |


































